首页 / 国际专利分类库 / 化学;冶金 / C07有机化学 / 杂环化合物 / 杂环化合物,含有硒原子或碲原子作为仅有的杂环原子的环
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
101 ネイティブライゲーション法 JP2015500863 2013-03-18 JP2015512376A 2015-04-27 メルニ オレ; レボー ローラン; オリビエ ナタリー
本発明は、セレニウム基により官能化されたペプチドを用いる1以上のネイティブライゲーション工程を含む、ポリペプチドの合成方法に関する。本発明はさらに、セレニウムおペプチド及び化合物に関する。【選択図】なし
102 有機セレン材料および有機発光デバイス内でのその使用 JP2011529209 2009-09-24 JP5676454B2 2015-02-25 チュアンジュン・シャ; レイモンド・クウォン; ビン・マー; チュン・リン
103 MONO-, OLIGO- AND POLYTHIENO [3,2-b] THIOPHENES JP2013197566 2013-09-24 JP2014062254A 2014-04-10 MARTIN HEENEY; WAGNER ROBERT; IAIN MCCULLOCH; STEVEN TIERNEY
PROBLEM TO BE SOLVED: To provide novel mono-, oligo- and polythieno[3,2-b]thiophenes, giving organic polymers improved in charge mobility and solubility, and favorable to synthesize.SOLUTION: This invention provides monomers, oligomers and polymers containing structures selected from the following formulae or the like.
104 Heterocyclic fused selenophene monomer JP2008179482 2008-07-09 JP5350695B2 2013-11-27 ツァーン シュテッフェン; エー.コステロ キャリー; マクローズ マーク
A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
105 Its use in organic selenium material and organic light emitting devices JP2011529209 2009-09-24 JP2012503889A 2012-02-09 チュアンジュン・シャ; チュン・リン; ビン・マー; レイモンド・クウォン
The present invention provides organoselenium compounds comprising dibenzoselenophene, benzo[b]selenophene or benzo[c]selenophene and their uses in organic light emitting devices.
106 Selenophene and selenophene-based polymers, their preparation, and their use JP2010523645 2008-09-10 JP2011517701A 2011-06-16 ウィスブン、ヤーハイム; ザデ、サンジオ・エス; ザモシュチック、ナタリア; シェイニン、ヤナ; パトラ、アシット; ベンディコフ、マイケル; リ、マオ
This invention is directed to selenophene compounds, selenophene-based polymers (polyselenophene), processes for the preparation of the same and uses thereof. The polyselenophenes of this invention have high conductivity and can be used as electrodes in various devices such as in electrochromic devices, batteries, solar cells, optical amplifiers, organic light emitting diodes, and the like.
107 Heterocyclic fused selenophene monomer JP2010004994 2010-01-13 JP2010163433A 2010-07-29 ZAHN STEFFEN; CARR RICHARD V C; HAUSE ROBERTA KATHLEEN; COSTELLO CARRIE A; MCLAWS MARK
<P>PROBLEM TO BE SOLVED: To provide a method for producing a monomer forming an electrically conductive polymer for wide-ranging electronic applications. <P>SOLUTION: The method for producing a compound having formula (1) includes a step of preparing a first reactant having formula (2); a step of reducing the first reactant in the presence of a metal reducing agent to form a second reactant having formula (3); a step of reacting the second reactant with a substituted 1-alkyne in the presence of a transition metal catalyst; a step of reacting a third reactant having formula (4) with an alkyllithium in the presence of an X-containing compound to form a fourth reactant having formula (5); and a step of reacting the fourth reactant with water to form the compound having formula (1). <P>COPYRIGHT: (C)2010,JPO&INPIT
108 New bichalcophene as antiprotozoal medicine and its prodrug JP2006139710 2006-05-19 JP2006328065A 2006-12-07 WERBOVETZ KARL; BRUN RETO; TIDWELL RICHARD R; BOYKIN DAVID W; STEPHENS CHAD E; ISMAIL MOHAMED A; WILSON W DAVID
<P>PROBLEM TO BE SOLVED: To provide new dication bichalcophene compounds. <P>SOLUTION: The new dication bichalcophene compounds disclosed in the present specification exhibit in vitro activity equivalent to those of pentamidine and furamidine against Trypanosoma brucei rhodesiense, Plasmodium falciparum or Leishmania donovani. Several compounds of these new dication bichalcophene compounds exhibit good in vivo activity in rat models affected by Trypanosoma brucei rhodesiense infectious disease. <P>COPYRIGHT: (C)2007,JPO&INPIT
109 Heteroarenediyl carboxamide for use as a dopamine -d3 ligand for the treatment of diseases of the central nervous system JP2004518667 2003-07-02 JP2005538974A 2005-12-22 シュロッター カーリン; ヒュプナー ハラルト; グマイナー ペーター
本発明は一般式(I)のニューロレセプター活性N−[(4−フェニル−1−ピペラジニル)アルキル]置換ヘテロアレーンカルボキサミドおよび構造類似体、一般式(II)の2−フェロセニル化合物および中枢神経の病気、例えば精神分裂病、種々の形の鬱病、神経変性疾患、性機能障害、コカイン、アルコール、アヘンおよびニコチン中毒、更に緑内障、認知障害、レストレスレッグ症候群、運動過多症候群(ADHS)、高プロラクチン血症、高プロラクチン産生腫瘍、パーキンソン病に関係する運動障害、L−DOPAおよび神経弛緩薬誘発性運動障害、例えば静座不能、硬直、失調症および運動異常を治療するためのこれらの使用に関し、置換基は発明の詳細な説明に記載される。
110 Glycosidase inhibitors and methods for their synthesis JP2001550214 2001-01-05 JP2003519220A 2003-06-17 ガバミ、アフマド; ディ. ジョンストン、ブレア; エム. ピント、ブライアン
(57)【要約】 本発明は、式(I)を有するサラシノール、及び立体異性体、並びにそれらの非天然セレニウム及び窒素類似体を合成する方法に関する。 本化合物は、グリコシダーゼ阻害剤として潜在的に有用である。 その合成スキームは、環状硫酸エステルとヘテロ原子(X)を含む5員環糖の反応を含む。 ヘテロ原子は、好ましくは、イオウ、セレニウム又は窒素を含む。 環状硫酸エステル及び環糖試薬は、D−グルコース、L−グルコース、D−キシロース及びL−キシロースなどの炭化物前駆体から容易に調製し得る。 標的化合物は、5員環糖のヘテロ原子の求核的攻撃により環状硫酸エステルを開環して調製する。 得られた複素環化合物は、ヘテロ原子陽イオンと硫酸陰イオンを含む安定な内部塩構造を有する。 本合成スキームにより、限られた副反応で、種々の標的化合物の立体異性体を適度から良好な収量で得る。 本発明の択一的実施形態において、環状硫酸エステルを、ヘテロ原子(X)を含む6員環糖と同様に反応させて式(XII)を有する化合物を産し得る。 【化42】
111 Fluoroalkylonium salt type cation or acid generating agent which generates cation or acid when irradiated with energy beam JP2000068241 2000-03-13 JP2001255647A 2001-09-21 ADACHI KENJI; ISHIHARA SUMI
PROBLEM TO BE SOLVED: To provide a cation or acid generating agent suitable for use in a chemical amplification type resist material, having high sensitivity to energy beams and capable of generating a cation or acid. SOLUTION: The cation or acid generating agent comprises an energy beam sensitive fluoroalkylonium salt of formula (1) in which groups R1-R3 (alkyl, aryl or the like) and a group Rf (fluoroalkyl) combine with the central element A (I, S, Se, Te, N or P). The chemical amplification type resist material is obtained by blending the acid generating agent.
112 Novel thioxanthene and seleno xanthene derivative JP34980391 1991-12-10 JPH0791287B2 1995-10-04 カルルハインツ・プフエルトナー; ハンス−ユルゲン・ハンゼン
113 Selenoxanthene compound JP181494 1994-01-13 JPH06340656A 1994-12-13 EREN EMU BAAMAN; EICHI DEII HORISU SHIYOUOORUTA; BURATSUDO EDOWAADO GUREGOO
PURPOSE: To provide a selenoxanthene compound useful as intermediates for preparation of benzoselenino[4,3,2-cd]indazole compds. which is useful as antibacterial agents, antifungal agents and antitumor agents. CONSTITUTION: A compound of formula I (R 7-R 10 are each H, OH or 1-4C alkoxy), such as 1-chloro-4-nitro-9H-selenoxanthen-9-one, are provided. The compd. is obtained by reacting 0-selenocyanobenzoic acid of formula II with 2,4-dichloronitrobenzene and cycling the obtained 2-[(5-chloro-2-nitrophenyl) seleno]benzoic acid of formula IV with phosphorus pentaoxide and methanesulfonic acid. A benzoselenino[4,3,2-cd]indazole compd. of formula V (R 2 is ANR'R" (A is 2-5C alkylene chain optionally substd. with OH; R' and R" are each H or 1-4C alkyl optionally substd. with OH) can be prepared by reacting the cycled compd. with R 2-substd. hydrazine. COPYRIGHT: (C)1994,JPO
114 New thioxanthene and selenoxthantene derivative JP34980391 1991-12-10 JPH06293752A 1994-10-21 HANSUUYURUGEN HANZEN; KARURUHAINTSU PUFUERUTONAA
PURPOSE: To provide new compds. useful as photosensitizes for conversion of tachysterol into previtamin D. CONSTITUTION: The derivs. are the compds. of formula I (R 1-R 4 are each H or Cl; R 5 is -COOMe or -SO 6Me; Me is alkali metal cation; Z is S or selenium), for example, 0-(6-hydroxy-3-oxo-3H-thioxanthine-9-yl)-benzenesulfonoc acid. The compds. of formula I are obtained by heating m,m'-selenodiphenol with the compds. of formula II or formula III, preferably in the presence of p- toluenesulfonic acid or trifluoromethanesulfonic acid, at 80-140°C. By using the compds. of formula I, tachysterol is able to convert to previtamin D substantially excluding tachysterol by light irradiation of 400-600 nm to the mixture of previtamin D and tachysterol. COPYRIGHT: (C)1994,JPO
115 Benzoserenino [4,3,2-cd] indazole compounds and their preparation JP14070885 1985-06-28 JPH0655745B2 1994-07-27 EREN EMU BAAMAN; EICHI DEII HORISU SHOOORUTAA; BURATSUDO EDOWAADO GUREGOO
116 JPH0434990B2 - JP13414084 1984-06-30 JPH0434990B2 1992-06-09 HANSUUYURUGEN HANZEN; KARURUHAINTSU PUFUERUTONAA
117 (perfluoroalkyl)dibenzonium salt and intermediate for producing the same JP2727090 1990-02-08 JPH03197479A 1991-08-28 UMEMOTO TERUO; ISHIHARA SUMI
NEW MATERIAL:A compound expressed by formula I (Rf is 1-10C perfluoroalkyl; A is S or Se; R 1 and R 2 are H or nitro; X - is conjugated base of Brensted acid; (n) is 0 or 1). EXAMPLE: S-(Trifluoromethyl)dibenzothiophenium tetrafluoroborate expressed by formula II. USE: A reagent for introducing fluoroalkyl groups into carbanions. PREPARATION: A diphenyl compound expressed by formula III is made to react with a perfluoroalkyl halide expressed by the formula RfY (Y is I or Br) under alkaline conditions, as necessary, while being irradiated with light to provide a perfluoroalkyldiphenyl compound expressed by formula IV, which is then allowed to react with F 2, Cl 2, XH (XH is Brensted acid) or X' (X' is Lewis acid). COPYRIGHT: (C)1991,JPO&Japio
118 Difluorinated (5,6,11,12-tetraselenotetracene)2halide, manufacture and use JP23816886 1986-10-08 JPS6299382A 1987-05-08 BURUUNO HIRUTEI; KAARU BUEE MAIYAA
119 Amidinohydrazones of derivatives of tetraline, chromone, thiochromone and tetrahydroquinoline JP9239085 1985-05-01 JPS60239454A 1985-11-28 HARUTOMUUTO SHIYUTEEGERUMAIAA; FURANKU YOAHIMU MOORITSUHI; ANDOREASU KUNORU
120 Manufacture of previtamine d JP13414084 1984-06-30 JPS6025965A 1985-02-08 HANSUUYURUGEN HANZEN; KARURUHAINTSU PUFUERUTONAA
QQ群二维码
意见反馈